Used in biomedical research to quantify levels of Bcl-2 protein in rat samples, particularly in studies related to apoptosis, cancer development, and immune system regulation. Commonly applied in oncology and immunology research to assess the role of Bcl-2 in lymphoma progression and response to therapeutic agents. Enables high-throughput screening of drug effects on anti-apoptotic pathways in rat B cell models. Widely used in preclinical studies to evaluate potential treatments targeting cell survival mechanisms.